SFTPB and newborn respiratory distress syndrome: Deficiency of endogenous pulmonary surfactant in premature children leads to neonatal respiratory distress syndrome (RDS) that can be efficiently treated with intratracheal instillation of animal-derived surfactant preparations containing phospholipids and the hydrophobic proteins SP-B and SP-C [7].